![JCM | Free Full-Text | Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression JCM | Free Full-Text | Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression](https://www.mdpi.com/jcm/jcm-09-03695/article_deploy/html/images/jcm-09-03695-g001.png)
JCM | Free Full-Text | Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression
![IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations](https://www.mdpi.com/ijms/ijms-24-03177/article_deploy/html/images/ijms-24-03177-g001.png)
IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations
![Current Oncology | Free Full-Text | Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia Current Oncology | Free Full-Text | Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia](https://www.mdpi.com/curroncol/curroncol-30-00148/article_deploy/html/images/curroncol-30-00148-g004.png)
Current Oncology | Free Full-Text | Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia
![Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment](https://pub.mdpi-res.com/diagnostics/diagnostics-11-00853/article_deploy/html/images/diagnostics-11-00853-g004.png?1621600903)
Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
![Cancers | Free Full-Text | Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma Cancers | Free Full-Text | Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma](https://www.mdpi.com/cancers/cancers-14-01489/article_deploy/html/images/cancers-14-01489-g001-550.jpg)
Cancers | Free Full-Text | Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
![Assessment of novel halo- and thermotolerant desert cyanobacteria for phycobiliprotein production - ScienceDirect Assessment of novel halo- and thermotolerant desert cyanobacteria for phycobiliprotein production - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359511322001337-ga1.jpg)
Assessment of novel halo- and thermotolerant desert cyanobacteria for phycobiliprotein production - ScienceDirect
![Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets](https://www.mdpi.com/cells/cells-07-00176/article_deploy/html/images/cells-07-00176-g001.png)
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
![IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations](https://www.mdpi.com/ijms/ijms-24-03177/article_deploy/html/images/ijms-24-03177-g001-550.jpg)
IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations
![Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment](https://pub.mdpi-res.com/diagnostics/diagnostics-11-00853/article_deploy/html/images/diagnostics-11-00853-ag.png?1621600904)
Diagnostics | Free Full-Text | The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
![IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations](https://www.mdpi.com/ijms/ijms-24-03177/article_deploy/html/images/ijms-24-03177-g004.png)
IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations
![IJMS | Free Full-Text | Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers IJMS | Free Full-Text | Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers](https://www.mdpi.com/ijms/ijms-24-10374/article_deploy/html/images/ijms-24-10374-g002.png)
IJMS | Free Full-Text | Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
![Cancers | Free Full-Text | Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials Cancers | Free Full-Text | Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials](https://pub.mdpi-res.com/cancers/cancers-11-00011/article_deploy/html/images/cancers-11-00011-g004.png?1570861396)
Cancers | Free Full-Text | Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials
![IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations](https://pub.mdpi-res.com/ijms/ijms-24-03177/article_deploy/html/images/ijms-24-03177-ag.png?1675668737)
IJMS | Free Full-Text | Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations
![Single-step purified R-phycoerythrin transmits cellular imaging functionalities in vitro - ScienceDirect Single-step purified R-phycoerythrin transmits cellular imaging functionalities in vitro - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0141813021025034-ga1.jpg)
Single-step purified R-phycoerythrin transmits cellular imaging functionalities in vitro - ScienceDirect
![JCM | Free Full-Text | Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3 JCM | Free Full-Text | Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3](https://www.mdpi.com/jcm/jcm-10-03735/article_deploy/html/images/jcm-10-03735-g001.png)
JCM | Free Full-Text | Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3
![Cancers | Free Full-Text | Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials Cancers | Free Full-Text | Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials](https://pub.mdpi-res.com/cancers/cancers-11-00011/article_deploy/html/images/cancers-11-00011-g001.png?1570861396)